L Holubec
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Protease and Inhibitor Mechanisms
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Drug Transport and Resistance Mechanisms
- Peptidase Inhibition and Analysis
Papers in
- Oncology 27
- Colorectal Cancer Treatments and Studies 10
- Cancer Treatment and Pharmacology 4
-
- Gastric Cancer Management and Outcomes 6
- Prostate Cancer Treatment and Research 3
- Co-authors
- Ondřej Topolčan (55 shared papers)Václav Liška (28 shared papers)Vladislav Třeška (26 shared papers)Jindřich Fínek (39 shared papers)Martin Pešta (22 shared papers)R. Lamerz (4 shared papers)Andrea Nicolini (2 shared papers)C. Sturgeon (2 shared papers)
- Journals
- Anticancer Research (4 papers)International Journal of Cancer (2 papers)Urology (2 papers)Annals of Oncology (2 papers)Tumor Biology (2 papers)
- Partner nations
- CzechiaUnited KingdomGermany
In The Last Decade
L Holubec
88 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 111
- Cancer Research 567
- Oncology 686
- Genetics 127
- Pathology and Forensic Medicine 166
- Molecular Biology 608
Countries citing papers authored by L Holubec
This map shows the geographic impact of L Holubec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Holubec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Holubec more than expected).
Fields of papers citing papers by L Holubec
This network shows the impact of papers produced by L Holubec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Holubec. The network helps show where L Holubec may publish in the future.
Co-authors
The 25 scholars most cited alongside L Holubec, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 276 | |
| 2 | 2012 | 192 | |
| 3 | 2010 | 132 | |
| 4 | 2017 | 104 | |
| 5 | Biological activity and clinical implications of the matrix metalloproteinases. | 2008 | 89 |
| 6 | 2010 | 76 | |
| 7 | 2012 | 64 | |
| 8 | Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease. | 2009 | 63 |
| 9 | 2008 | 55 | |
| 10 | 2016 | 42 | |
| 11 | 2015 | 41 | |
| 12 | 2016 | 40 | |
| 13 | Importance of miR-20a expression in prostate cancer tissue. | 2010 | 39 |
| 14 | Prognostic significance of TIMP-1 in non-small cell lung cancer. | 2011 | 37 |
| 15 | A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer. | 2009 | 37 |
| 16 | Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples. | 2005 | 37 |
| 17 | Differential display code 3 (DD3/PCA3) in prostate cancer diagnosis. | 2010 | 28 |
| 18 | 2007 | 27 | |
| 19 | Cytokeratin serum biomarkers in patients with colorectal cancer. | 2012 | 26 |
| 20 | 2003 | 25 |
About L Holubec
L Holubec is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Epidemiology, having authored 92 papers that have together received 2.0k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (10 papers), Gastric Cancer Management and Outcomes (6 papers), Protease and Inhibitor Mechanisms (6 papers), Genetic factors in colorectal cancer (5 papers), Cancer Treatment and Pharmacology (4 papers), Neuroendocrine Tumor Research Advances (4 papers), Liver physiology and pathology (3 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Cancer Research (567 citations), Oncology (686 citations), Genetics (127 citations), Pathology and Forensic Medicine (166 citations) and Molecular Biology (608 citations). L Holubec has collaborated with scholars based in Czechia, United Kingdom and Germany. Frequent co-authors include Ondřej Topolčan, Václav Liška, Vladislav Třeška, Jindřich Fínek, Martin Pešta, R. Lamerz, Andrea Nicolini, C. Sturgeon, Caj Haglund and Michael J. Duffy. Their work appears in journals such as Anticancer Research, International Journal of Cancer, Urology, Annals of Oncology and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.